Atlas Trials

Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases

Clinical trial NCT06848842 · RECRUITING

Trial details

NCT number
NCT06848842
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Liver Metastases
Start date
2025-09-18
Primary completion
2027-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.